Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.
BACKGROUND
Gastroesophageal reflux disease (GORD) is said to be the causative factor in up to 41% of adults with chronic cough. Treatment for GORD includes conservative measures (diet manipulation), pharmaceutical therapy (motility or prokinetic agents, H(2)-antagonist and proton pump inhibitors (PPI)) and fundoplication.


OBJECTIVE
To evaluate the efficacy of GORD treatment on chronic cough in children and adults with GORD and prolonged cough that is not related to an underlying respiratory disease, i.e. non-specific chronic cough.


METHODS
We searched the Cochrane Airways Group Specialised Register, the Cochrane Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, review articles and reference lists of relevant articles. The date of last search was 8 April 2010.


METHODS
All randomised controlled trials (RCTs) on GORD treatment for cough in children and adults without primary lung disease.


METHODS
Two review authors independently assessed trial quality and extracted data. We contacted study authors for further information.


RESULTS
We included 19 studies (six paediatric, 13 adults). None of the paediatric studies could be combined for meta-analysis. A single RCT in infants found that PPI (compared to placebo) was not efficacious for cough outcomes (favouring placebo OR 1.61; 95% CI 0.57 to 4.55) but those on PPI had significantly increased adverse events (OR 5.56; 95% CI 1.18 to 26.25) (number needed to treat for harm in four weeks was 11 (95% CI 3 to 232)). In adults, analysis of H(2) antagonist, motility agents and conservative treatment for GORD was not possible (lack of data) and there were no controlled studies of fundoplication. We analysed nine adult studies comparing PPI (two to three months) to placebo for various outcomes in the meta-analysis. Using intention-to-treat, pooled data from studies resulted in no significant difference between treatment and placebo in total resolution of cough (OR 0.46; 95% CI 0.19 to 1.15). Pooled data revealed no overall significant improvement in cough outcomes (end of trial or change in cough scores). We only found significant differences in sensitivity analyses. We found a significant improvement in change of cough scores at end of intervention (two to three months) in those receiving PPI (standardised mean difference -0.41; 95% CI -0.75 to -0.07) using generic inverse variance analysis on cross-over trials. Two studies reported improvement in cough after five days to two weeks of treatment.


CONCLUSIONS
PPI is not efficacious for cough associated with GORD symptoms in very young children (including infants) and should not be used for cough outcomes. There is insufficient data in older children to draw any valid conclusions. In adults, there is insufficient evidence to conclude definitely that GORD treatment with PPI is universally beneficial for cough associated with GORD. Clinicians should be cognisant of the period (natural resolution with time) and placebo effect in studies that utilise cough as an outcome measure. Future paediatric and adult studies should be double-blind, randomised controlled and parallel-design, using treatments for at least two months, with validated subjective and objective cough outcomes and include ascertainment of time to respond as well as assessment of acid and/or non-acid reflux.
Royal Children's Hospital, Brisbane and Menzies School of Health Research, CDU, Darwin, Queensland Children's Respiratory Centre and Queensland Children's Medical Research Institute, Herston Road, Herston, Brisbane, Queensland, Australia, 4029.
Anne B
AB
Chang
Toby J
TJ
Lasserson
Justin
J
Gaffney
Frances L
FL
Connor
Luke A
LA
Garske
D000328:Adult; D000367:Age Factors; D002648:Child; D002908:Chronic Disease; D003371:Cough / Q000209:etiology / Q000628:therapy*; D005764:Gastroesophageal Reflux / Q000150:complications / Q000628:therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors
ANZ J Surg. 2003 Apr;73(4):189-93
12662224
J Pediatr. 2009 Apr;154(4):514-520.e4
19054529
Dig Dis Sci. 2007 Feb;52(2):463-8
17211695
Chest. 1993 Nov;104(5):1511-7
8222816
Gastroenterology. 1996 Jun;110(6):1981
8964427
Respirology. 1997 Dec;2(4):309-16
9525303
Postgrad Med J. 1996 Oct;72(852):594-8
8977940
Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943
16928254
Chest. 2002 Apr;121(4):1123-31
11948042
Ann Thorac Surg. 2002 Feb;73(2):381-5
11845846
Am J Gastroenterol. 1999 Nov;94(11):3131-8
10566703
Nat Clin Pract Gastroenterol Hepatol. 2007 Nov;4(11):604-13
17978817
Am J Surg. 2003 May;185(5):455-61
12727567
J Laryngol Otol. 2000 Jun;114(6):441-7
10962677
Dig Liver Dis. 2006 Jul;38(7):452-8
16631423
Dig Dis Sci. 2008 Aug;53(8):2033-8
18080197
Surg Endosc. 2009 Feb;23(2):423-31
18814008
Surg Endosc. 2002 Apr;16(4):567-71
11972189
J Pediatr. 1992 Dec;121(6):913-5
1447654
Pulm Pharmacol Ther. 2002;15(3):303-8
12099783
Dis Esophagus. 2007;20(2):155-60
17439600
Eur Respir J. 1994 Jul;7(7):1246-53
7925902
J Asthma. 1999 Dec;36(8):631-44
10609618
JAMA. 2004 Oct 27;292(16):1955-60
15507580
J Laryngol Otol. 2004 Jan;118(1):25-30
14979968
Eur Respir J. 2002 Aug;20(2):268-73
12212954
J Voice. 2002 Sep;16(3):425-32
12395996
Dig Dis Sci. 1995 May;40(5):1093-7
7729270
Clin Gastroenterol Hepatol. 2006 Apr;4(4):433-41
16616347
BMJ. 1998 Nov 7;317(7168):1309-12
9804726
Ann Otol Rhinol Laryngol. 2006 Oct;115(10):754-8
17076097
Chest. 2008 Feb;133(2):386-95
18252913
Laryngoscope. 2006 Feb;116(2):254-60
16467715
JAMA. 2004 Oct 27;292(16):2012-3
15507589
J Gastrointest Surg. 2002 Jan-Feb;6(1):17-21
11986013
J Pediatr Gastroenterol Nutr. 2008 May;46(5):524-33
18493207
Am J Med. 2003 Aug 18;115 Suppl 3A:65S-71S
12928078
Thorax. 2003 Apr;58(4):339-43
12668799
Am Rev Respir Dis. 1990 Mar;141(3):640-7
2178528
Dis Esophagus. 2002;15(4):309-14
12472478
Am J Gastroenterol. 1997 Dec;92(12):2160-5
9399745
Curr Opin Gastroenterol. 2007 Jul;23(4):434-9
17545782
Otolaryngol Head Neck Surg. 2004 Oct;131(4):342-50
15467597
Am J Gastroenterol. 2006 Sep;101(9):1972-8; quiz 2169
16968502
Clin Pediatr (Phila). 2003 Jul-Aug;42(6):483-95
12921449
Am J Gastroenterol. 1996 Oct;91(10):2110-3
8855731
World J Gastroenterol. 2006 Jan 7;12(1):82-8
16440422
Respir Med. 2000 Dec;94(12):1166-70
11192951
Am J Rhinol. 2007 Nov-Dec;21(6):695-701
18201449
Dysphagia. 1995 Spring;10(2):113-6
7600852
J Pediatr. 2006 Oct;149(4):468-74
17011315
Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):557-61
7842220
Thorax. 1998 Nov;53(11):963-8
10193396
Curr Ther Res Clin Exp. 2003 Apr;64(4):270-8
24944374
Am J Surg. 2001 May;181(5):466-70
11448445
Arch Dis Child. 1998 Jul;79(1):6-11
9771244
J Gastroenterol Hepatol. 2008 Jan;23(1):8-22
18171339
Am J Respir Crit Care Med. 2002 Nov 1;166(9):1206-11
12403689
Am J Gastroenterol. 2001 Apr;96(4):979-83
11316215
Acta Otolaryngol. 1993 May;113(3):405-8
8517146
Br J Surg. 2001 Dec;88(12):1649-52
11736981
Acta Otolaryngol. 2006 Aug;126(8):866-71
16846931
Int J Epidemiol. 2002 Feb;31(1):140-9
11914310
J Gastroenterol Hepatol. 2003 Feb;18(2):196-202
12542606
J Pediatr Gastroenterol Nutr. 2009 Oct;49(4):498-547
19745761
Pediatr Ann. 1996 Mar;25(3):162-8
8643327
Pediatr Pulmonol. 1999 Jul;28(1):59-70
10406052
JAMA. 2006 Dec 27;296(24):2947-53
17190895
Pulm Pharmacol Ther. 2002;15(3):261-6
12099775
Aust N Z J Surg. 2000 Dec;70(12):840-2
11167570
Eur J Pediatr. 1993 Sep;152(9):704-11
8223796
Am J Respir Crit Care Med. 1994 Jan;149(1):160-7
8111576
Otolaryngol Head Neck Surg. 2004 Nov;131(5):767-72
15523464
Ann Pharmacother. 2003 Nov;37(11):1607-9
14565840
J Asthma. 2001 Jun;38(4):299-309
11456383
Am J Gastroenterol. 2004 Jun;99(6):1037-43
15180722
Laryngoscope. 2001 Dec;111(12):2147-51
11802014
Chest. 2003 Mar;123(3):679-84
12628862
J Pediatr. 2001 Jul;139(1):7-9
11445783
J Pediatr Gastroenterol Nutr. 2001;32 Suppl 2:S1-31
11525610
J Laryngol Otol. 2004 Nov;118(11):845-8
15638969
J Clin Gastroenterol. 2007 Oct;41(9):823-9
17881928
Am J Respir Crit Care Med. 1994 Aug;150(2):374-80
8049818
Aliment Pharmacol Ther. 2007 Feb 15;25(4):385-92
17269993
J Pediatr. 1985 Feb;106(2):311-6
3968623
Allerg Immunol (Paris). 1994 Feb;26(2):53-8
8148045
Ann Surg. 1996 Jun;223(6):673-85; discussion 685-7
8645041
J Laryngol Otol. 1999 Aug;113(8):734-9
10748849
Arch Dis Child. 2003 Jan;88(1):57-60
12495964
Am Surg. 2003 Oct;69(10):833-8
14570358
Otolaryngol Head Neck Surg. 2008 Jan;138(1):57-61
18164994
Arch Dis Child. 2011 May;96(5):468-72
20515960
Eur Respir J. 2000 Oct;16(4):633-8
11106204
Scand J Gastroenterol. 2003 May;38(5):462-7
12795454
Arch Surg. 2000 May;135(5):545-9
10807278
Chest. 2002 Apr;121(4):1132-40
11948043
Eur Respir J. 1998 Feb;11(2):462-6
9551755
Cough. 2007 Mar 20;3:4
17374150
Am J Gastroenterol. 2006 Sep;101(9):2096-106
16817845
Chest. 1998 Aug;114(2 Suppl Managing):133S-181S
9725800
Surg Endosc. 2002 Jul;16(7):1037-41
12165818
Surg Endosc. 2004 Apr;18(4):633-7
15026893
Nucl Med Commun. 2008 Dec;29(12):1066-72
18987527
Ann Surg. 1990 Mar;211(3):337-45
2310240